α-Interferon treatment in Chinese patients with chronic hepatitis B
- 1 January 1990
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 11, S121-S125
- https://doi.org/10.1016/0168-8278(90)90177-s
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Randomized, controlled trial of recombinant human α-interferon in patients with chronic hepatitis BGastroenterology, 1988
- A longitudinal follow-up of asymptomatic hepatitis B surface antigen-positive chinese childrenHepatology, 1988
- LONG-TERM FOLLOW-UP IN A RANDOMISED CONTROLLED TRIAL OF RECOMBINANT α2-INTERFERON IN CHINESE PATIENTS WITH CHRONIC HEPATITIS B INFECTIONThe Lancet, 1988
- PLACEBO-CONTROLLED TRIAL OF RECOMBINANT α2-INTERFERON IN CHINESE HBsAg-CARRIER CHILDRENThe Lancet, 1987
- LOSS OF HBsAg WITH INTERFERON THERAPY IN CHRONIC HEPATITIS B VIRUS INFECTIONThe Lancet, 1987
- Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infectionGastroenterology, 1987
- Lymphoblastoid interferon therapy of chronic HBV infectionJournal of Hepatology, 1987
- A Randomized Study of the Effects of Adenine Arabinoside 5′–Monophosphate (Short or Long Courses) and Lymphoblastoid Interferon on Hepatitis B Virus ReplicationHepatology, 1985
- Recombinant Leukocyte Interferon Treatment of Chronic Hepatitis BHepatology, 1985
- PREVENTION OF THE HBsAg CARRIER STATE IN NEWBORN INFANTS OF MOTHERS WHO ARE CHRONIC CARRIERS OF HBsAg AND HBeAg BY ADMINISTRATION OF HEPATITIS-B VACCINE AND HEPATITIS-B IMMUNOGLOBULINThe Lancet, 1984